|
CD3 AK/IL-2加中药治疗原发性肝癌的研究获1999年度广西科技进步二等奖。图为疗效观察。
A study on CD3 AK/IL-2
combining with traditional Chinese medicine in treating
primary liver cancer, So the achievement won the second award
of " Guangxi scientific and technological progress
" in 1999, Therapeutic effect inquirty.
|
